Premium
Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptor
Author(s) -
FernandezGalar M.,
España A.,
LópezPicazo J. M.
Publication year - 2004
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/j.1365-2230.2004.01466.x
Subject(s) - medicine , epidermal growth factor receptor , dermatology , receptor
Summary Drugs that inhibit the epidermal growth factor receptor, such as ZD1839 or C225, are being used increasingly in the treatment of solid tumours. This has led to the appearance of new secondary effects. We describe the case of a patient who presented with an acneiform eruption secondary to the administration of ZD1839. These lesions healed in a few days after stopping the drug.